Cholesterol Ester Transfer Proteins
"Cholesterol Ester Transfer Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins that bind to and transfer CHOLESTEROL ESTERS between LIPOPROTEINS such as LOW-DENSITY LIPOPROTEINS and HIGH-DENSITY LIPOPROTEINS.
Descriptor ID |
D053480
|
MeSH Number(s) |
D09.400.430.750 D12.776.124.197 D12.776.157.165 D12.776.395.199
|
Concept/Terms |
Cholesterol Ester Transfer Proteins- Cholesterol Ester Transfer Proteins
- Cholesteryl Ester Exchange Protein
- Cholesteryl Ester Transfer Protein
- Cholesterol Ester Transport Protein, CETP
|
Below are MeSH descriptors whose meaning is more general than "Cholesterol Ester Transfer Proteins".
Below are MeSH descriptors whose meaning is more specific than "Cholesterol Ester Transfer Proteins".
This graph shows the total number of publications written about "Cholesterol Ester Transfer Proteins" by people in this website by year, and whether "Cholesterol Ester Transfer Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2006 | 1 | 0 | 1 |
2008 | 1 | 0 | 1 |
2017 | 4 | 1 | 5 |
2018 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Cholesterol Ester Transfer Proteins" by people in Profiles.
-
Lipid management in patients with chronic kidney disease. Nat Rev Nephrol. 2018 12; 14(12):727-749.
-
A translational evidence for cholesteryl ester transfer protein modulation by glucocorticoids: A time for reflection. Eur J Clin Invest. 2018 02; 48(2).
-
Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk. JAMA. 2017 09 12; 318(10):947-956.
-
Plasma lipoprotein subfraction concentrations are associated with lipid metabolism and age-related macular degeneration. J Lipid Res. 2017 09; 58(9):1785-1796.
-
Success, Failure, and Transparency in Biomarker-Based Drug Development: A Case Study of Cholesteryl Ester Transfer Protein Inhibitors. Circ Cardiovasc Qual Outcomes. 2017 Jun; 10(6).
-
Evacetrapib: Another CETP Inhibitor for Dyslipidemia With No Clinical Benefit. Cardiol Rev. 2017 Mar/Apr; 25(2):43-52.
-
HDL metabolism and CETP inhibition. Cardiol Rev. 2008 May-Jun; 16(3):154-62.
-
Cholesteryl ester transfer protein inhibition: the next frontier in combating coronary artery disease? J Am Coll Cardiol. 2006 Nov 07; 48(9):1791-2.